Drugs / ONO-5788
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03849872 | Feb → Apr 2019 | acromegaly | Ono Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 1 | NCT03571594 | Jun 2018 → May 2019 | acromegaly | Ono Pharmaceutical Co., Ltd. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ONO-5788 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03849872 ↗ |
| Route | Oral | “increasing doses of an oral solution or capsule” NCT03571594 ↗ |